ZNF90P3

Across TCGA pan-cancer cohorts, ZNF90P3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated ZNF90P3 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ZNF90P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF90P3 expression acts as an unfavorable survival marker.

ACC, LUSC, and READ are the cancer types where ZNF90P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.624	<.001	81	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	60	view →
READ	OS	Tertile	All	0.268	0.714	.020	33	view →
KIRC	OS	Tertile	All	0.673	0.812	.016	27	view →
BRCA	DFS	Tertile	II,III,IV	0.782	0.893	.022	24	view →
MESO	OS	Tertile	III,IV	0.176	0.572	.005	18	view →
LIHC	DFS	Tertile	III,IV	0.077	0.414	.004	9	view →
SKCM	DFS	Tertile	II,III,IV	0.305	0.594	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

ZNF90P3–ACC (DFS)

Open the ACC breakdown →